QuorumCivic. Hidden in plain sight Get the app
Bill intelligence
Full Simple

Medicare Advantage insurers lose power to deny care after approving it

H.R. 10394 — Protecting Approved Care Act · Filed by Greg Landsman (D-OH) · 5 cosponsors · Introduced Sep 15, 2026 · Referred to committee

85%
Transparency
Typical bill: 85%
15/100
Hidden-provision risk
Typical bill: 15/100
Medicare Advantage Claims Protection

Your members of Congress

Enter a ZIP to see where your representative and both senators stood on this bill.

Looked up on this device — your ZIP is never stored on our servers.

What it does

This bill prohibits Medicare Advantage plans from denying coverage or reopening claims after they have already approved an item or service through prior authorization or concurrent approval. Once an MA plan approves care (either before or during treatment), it cannot later deny that same care as medically unnecessary, reopen the approval without good cause or fraud evidence, or reduce payment by recoding the claim—protecting patients from surprise denials after care is delivered.

Why we flagged it

The bill's operative mechanism is a straightforward restriction on MA insurers' post-approval claim-denial practices. It does not create new benefits or spending; it constrains insurer discretion after approval has been granted, protecting the enforceability of prior authorizations.

What the text implies

  • MA plans may respond by tightening prior authorization criteria upfront, making initial approvals harder to obtain—shifting the denial burden earlier in the care pathway rather than eliminating it.
  • The bill's effective date (January 1, 2028) gives MA plans 16+ months to reprogram claims systems and authorization workflows, potentially creating a window of uncertainty about implementation.
  • Reopening restrictions tied to 'good cause' and 'reliable evidence of fraud' reference specific CFR sections (405.986, 422.616, 405.902); changes to those regulations could alter the bill's practical scope without amending this statute.
  • The bill does not address the underlying prior authorization burden itself—only the post-approval reversal problem—so patients may still face delays and denials at the authorization stage.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Patients enrolled in Medicare Advantage plans gain protection against the practice of insurers approving care upfront and then denying or reducing payment after delivery. This reduces financial uncertainty and surprise bills for seniors, and ensures that prior approvals are binding commitments rather than provisional placeholders.

Who stands to gain

  • Medicare Advantage enrollees (reduced risk of post-service claim denials)
  • Healthcare providers (reduced claim reversals and payment uncertainty)

Named in the bill

Medicare Advantage organizations, Social Security Act § 1857(e), 42 CFR § 405.986, 42 CFR § 422.616, 42 CFR § 405.902

Where it stands

5 cosponsors: 3 Republicans, 2 Democrats.

  • Sep 15, 2026 — Introduced · Congress.gov: “Introduced in House”
  • Sep 15, 2026 — Referred to House Committee on Energy and Commerce and House Committee on Ways and Means · Congress.gov: “Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a…”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

1 lobbying clients named this bill on 1 disclosure filings across 1 quarter, Sep 2026 to Sep 2026. Those filings disclosed $97,000 in lobbying spend. A filing names 2 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 0% of bills with at least one filing.

Greg Landsman, the sponsor, reported $1,117,228 in PAC receipts in the 2026 cycle.

  • Missouri Hospital Association — $97,000 on 1 filing

Lobbying Disclosure Act filings through Oct 19, 2026. A filing shows who paid to lobby on a bill it names, not what changed.

How this was measured

Analysis — Quorum's AI read the bill text published by Congress.gov (2,966 characters) on Sep 23, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 17,910 analysed bills.

Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.

Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Sep 2026 to Sep 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.

As of — lobbying records through Oct 19, 2026 · page rendered 2026-11-22.

“Medicare Advantage insurers lose power to deny care after approving it” QuorumCivic. https://share.quorumcivic.app/bill/119/hr10394 Report an error

Correlative observation from public records — not evidence of coordination or wrongdoing, and not financial advice.
This page is the record as of today. The app tells you when it changes.
Quorum analysis of the full bill text · 119th Congress · public record

The week in bills

One email, Sunday: what Congress passed, what it changed, and who paid.

One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.